Literature DB >> 23100480

Immune complexes isolated from patients with pulmonary tuberculosis modulate the activation and function of normal granulocytes.

P Senbagavalli1, J Nancy Hilda, V D Ramanathan, V Kumaraswami, Thomas B Nutman, Subash Babu.   

Abstract

Circulating immune complexes (ICs) are associated with the pathogenesis of several diseases. Very little is known about the effect of ICs on the host immune response in patients with tuberculosis (TB). The effects of ICs isolated from patients with TB in modulating the release of calcium, cytokines, and granular proteins were studied in normal granulocytes, as were their chemotactic, phagocytic, and oxidative burst processes. ICs from TB patients induced decreased production of cytokines and platelet-activating factor (PAF) from normal granulocytes. ICs from TB patients also induced enhanced chemotaxis and phagocytosis but caused diminished oxidative burst. This was accompanied by an increased release in intracellular calcium. On the other hand, ICs from TB patients induced increased release of the granular proteins human neutrophil peptides 1 to 3 (HNP1-3). Thus, ICs from patients with TB exhibit a profound effect on granulocyte function with activation of certain effector mechanisms and dampening of others.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23100480      PMCID: PMC3535873          DOI: 10.1128/CVI.00437-12

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  40 in total

Review 1.  IgG Fc receptors.

Authors:  J V Ravetch; S Bolland
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

Review 2.  Tissue injury in inflammation. Oxidants, proteinases, and cationic proteins.

Authors:  P M Henson; R B Johnston
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

Review 3.  Tissue injury in neutrophilic inflammation.

Authors:  F Dallegri; L Ottonello
Journal:  Inflamm Res       Date:  1997-10       Impact factor: 4.575

4.  Mycobacterium tuberculosis 19-kDa lipoprotein promotes neutrophil activation.

Authors:  C Neufert; R K Pai; E H Noss; M Berger; W H Boom; C V Harding
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

5.  Depressed phagocytosis and oxidative burst in polymorphonuclear leukocytes from individuals with pulmonary tuberculosis with or without human immunodeficiency virus type 1 infection.

Authors:  S Shalekoff; C T Tiemessen; C M Gray; D J Martin
Journal:  Clin Diagn Lab Immunol       Date:  1998-01

6.  Significance of circulating immune complexes in pulmonary tuberculosis.

Authors:  A M Samuel; M D Ashtekar; R D Ganatra
Journal:  Clin Exp Immunol       Date:  1984-11       Impact factor: 4.330

7.  Immunoprofile studies in patients with pulmonary tuberculosis. III. Study of haemolytic complement in serum and phagocytic activity of blood neutrophils.

Authors:  M Rieger; L Trnka; J Skvor; P Mison
Journal:  Scand J Respir Dis       Date:  1979-08

8.  Circulating immune complexes in tuberculosis.

Authors:  N M Johnson; M W McNicol; E J Burton-Kee; J F Mowbray
Journal:  Thorax       Date:  1981-08       Impact factor: 9.139

9.  Host response of platelet-activating factor receptor-deficient mice during pulmonary tuberculosis.

Authors:  Sebastiaan Weijer; Jaklien C Leemans; Sandrine Florquin; Takao Shimizu; Satoshi Ishii; Tom van der Poll
Journal:  Immunology       Date:  2003-08       Impact factor: 7.397

10.  Blood levels of PAF are elevated during induction of immune complex mediated enteropathy in the rat.

Authors:  K J Bloch; B P Ng; M Bloch
Journal:  Mediators Inflamm       Date:  1992       Impact factor: 4.711

View more
  7 in total

1.  Identification of Leishmania donovani antigen in circulating immune complexes of visceral leishmaniasis subjects for diagnosis.

Authors:  Fauzia Jamal; Pushkar Shivam; Sarita Kumari; Manish Kumar Singh; Abul Hasan Sardar; Selvasankar Murugesan; Shyam Narayan; Anil Kumar Gupta; Krishna Pandey; V N R Das; Vahab Ali; Sanjiva Bimal; Pradeep Das; Shubhankar K Singh
Journal:  PLoS One       Date:  2017-08-18       Impact factor: 3.240

2.  Glycoproteins in circulating immune complexes are biomarkers of patients with Indian PKDL: A study from endemic districts of West Bengal, India.

Authors:  Priyank Jaiswal; Souvik Datta; Bikash Sardar; Surya Jyoti Chaudhuri; Dipankar Maji; Manab Ghosh; Bibhuti Saha; Sumi Mukhopadhyay
Journal:  PLoS One       Date:  2018-02-08       Impact factor: 3.240

3.  Protective effect of antigen excess immune complex in guinea pigs infected with Mycobacterium tuberculosis.

Authors:  Rajadas Sam Ebenezer; Umesh D Gupta; Pushpa Gupta; Harshavardhan Shakila
Journal:  Indian J Med Res       Date:  2017-11       Impact factor: 2.375

4.  High occurrence of simultaneous multiple-drug hypersensitivity syndrome induced by first-line anti-tuberculosis drugs.

Authors:  Da Woon Sim; Hye Su You; Ji Eun Yu; Young-Il Koh
Journal:  World Allergy Organ J       Date:  2021-07-28       Impact factor: 4.084

5.  [Comparison of Clinical Outcomes of VATS and SBRT in the Treatment of NSCLC].

Authors:  Jiandong Wang; Zhanjie Zuo; Hongbo Zhang; Wei Li; Kunfeng Wang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2016-03

Review 6.  Eosinophil Polymorphonuclear Leukocytes in TB: What We Know so Far.

Authors:  Senbagavalli Prakash Babu; Prakash B Narasimhan; Subash Babu
Journal:  Front Immunol       Date:  2019-11-14       Impact factor: 7.561

Review 7.  Role of Circulating Immune Complexes in the Pathogenesis of Canine Leishmaniasis: New Players in Vaccine Development.

Authors:  Cristina Cacheiro-Llaguno; Nuria Parody; Marta R Escutia; Jerónimo Carnés
Journal:  Microorganisms       Date:  2021-03-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.